Phanes Biotech Alternatives & Competitors

12 companies similar to Phanes Biotech — " Shifting the balance from NeuroDegeneration to NeuroRegeenration"

Asceneuron SA

Targeting the root cause of neurodegeneration

20 Series C $130.00M

Lausanne, Switzerland

Biotechnology Health Care +1

AXON Neuroscience

Independent clinical stage biotech company.

Bratislava, Slovakia

Health Care Information Technology +1

Amyl Therapeutics

Restoring clarity in amyloid diseases

11 Grant $29.70M

Liege, Belgium

Biotechnology Health Care +1

Neurotrope Inc.

Developing a new approach to combating Alzheimer's disease and other neurodegenerative dis...

3 Series A $21.90M

New York, United States

Biotechnology Health Care

Track all Phanes Biotech competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Alector

We are on a mission to make brain disorders history.

141 IPO $495.50M

South San Francisco, Unit...

Biotechnology Health Care +2

Vigil Neuroscience

Harnessing the power of microglia to transform treatments for neurodegenerative diseases

76 Acquired $650.00M

Watertown, United States

Biotechnology Health Care

Wren Therapeutics

Stopping the wave of neurodegeneration at its source

34 Venture round $30.40M

Cambridge, United Kingdom

Biopharma Biotechnology +2

Therini Bio, Inc.

A new approach to block vascular-mediated inflammation

15 Series A $65.35M

Sacramento, United States

Biotechnology Health Care +1

ProteoTech

Advancing Therapeutics and Diagnostics for Amyloid Diseases Since 1996

2-10 Venture round $10.54M

Biotechnology Health Care

AmyPore

New target, new paradigm, new strategy that address the root cause of Alzheimer, Parkinson...

2 Non Equity Assistance $71.43K

Septemes-les-vallons, Fra...

Biotechnology Health Care +1

AIRAmed GmbH

AI software optimzes neuroradiological diagnostic and enables early detection of Alzheimer...

Tubingen, Germany

AI Health Care

ALSP, Inc.

Pioneering small molecule therapies for neurodegenerative diseases, focusing on innovative...

2 Debt Financing $1.15M

La Jolla, United States

Biotechnology Health Care +1

About Phanes Biotech

Phanes Biotech is an early-stage biotechnology company founded in 2020, with a primary focus on developing molecules to address neurodegenerative diseases and developmental disabilities through neural regeneration. The company's mission is encapsulated in its slogan: "Shifting the balance from NeuroDegeneration to Neur...

Business keywords

Neurodegenerative Diseases, Neuroregeneration, Drug Development, Tau Immunotherapy, Alzheimer's Disease, Macular Degeneration, Dementia, Amyloid, Neural Regeneration, Developmental Disabilities

Frequently Asked Questions

Companies similar to Phanes Biotech include Asceneuron SA, AXON Neuroscience, Amyl Therapeutics, Neurotrope Inc., Alector. They work in Health Care and share Phanes Biotech's focus on neurodegenerative diseases, alzheimer's disease and drug development.

Bounce Watch lists 12 companies that share Phanes Biotech's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Phanes Biotech and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Phanes Biotech Profile Asceneuron SA Alternatives AXON Neuroscience Alternatives Amyl Therapeutics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Phanes Biotech on 4 Dec 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 16 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.